A Multidisciplinary Approach to the Diagnosis and Treatment of Chronic Dry Eye Disease

A Multidisciplinary Approach to the Diagnosis and Treatment of Chronic Dry Eye Disease

On-Demand Webcast

Preeya K. Gupta, MD
Associate Professor of Ophthalmology
Cornea & Refractive Surgery
Duke University Eye Center
Durham, North Carolina

Christopher E. Starr, MD
Associate Professor of Ophthalmology
Director, Cornea Fellowship Program
Director, Refractive Surgery Service
Director, Ophthalmic Education
Weill Cornell Medicine
New York-Presbyterian Hospital
New York, New York

Intended Learners

 Ophthalmologists, optometrists, and related health care providers involved in the care of DED patients, including PCPs, nurse practitioners, physician assistants, nurses, and pharmacists.

Learning Objectives

After completing this activity, participants should be able to

  • Identify the signs, symptoms, and risk factors associated with DED
  • Apply traditional and newly developed tools to accurately diagnose DED
  • Discuss the full treatment armamentarium for DED, including recent developments in prescription therapies
  • Design a multifaceted treatment plan to advise patients on the management of DED
Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Release Date: December 8, 2017
Expiration Date: December 8, 2018
Estimated time to complete: 1 hour

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring webcast.


  In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

This continuing nursing education activity awards 1 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1 contact hour.

Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements. 

Planning Committee

The planning committee comprises Preeya Gupta, MD, Christopher Starr, MD, Robert Gentile, MD, Amy Ghiretti, Todd Kunkler, MaryEllen Fama, Mary Johnson, Mike Kearney, Randy Robbin, and John Savage, NACCME.

Independent Clinical Reviewer: Ronald C. Gentile, MD, FACS, FASRS, New York Eye and Ear Infirmary of Mount Sinai, New York, New York

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Gupta: Consultant – Tear Science, Shire, Allergan, Biotissue, Novabay Pharmaceuticals, JNJ Vision, Alcon, Tear Lab, Aurea, Ocular Science, Zeiss

Dr. Starr: Consultant – Allergan, Alcon / Novartis, Bausch & Lomb / Valeant, Shire, Bruder, Blephex, TearLab, RPS, Sun, Kala

Ms. Seaman: Advisory Board – MoInlycke Health Care

Ms. Fama, Dr. Gentile, Ms.Ghiretti, Mr. Kunkler, Ms. Johnson, Mr. Kearney, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculties have disclosed no off label/unapproved uses of drugs and/or devices will be discussed in the presentations.

Brand Name Disclosure

This continuing medical education activity may include medication brand names for participant clarity purposes only, due to the presence of different branded versions of the same agent. No product promotion or recommendation should be inferred.

For CE inquiries, please contact NACCME at 609-371-1137, ext. 6219.

Device Name Disclosure

This continuing medical education activity may include device brand names for participant clarity purposes only, due to the presence of different branded versions of the same device. No product promotion or recommendation should be inferred. 

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

ADA Statement

North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2017 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering

Provided by North American Center for Continuing Medical Education, LLC, An HMP Company.

Grant Support

This activity is supported by an educational grant from Allergan, Inc.